Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).

Novartis Media Relations E-mail: [email protected] Novartis Investor Relations Central investor relations line: +41 ...

Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseases ...

First p articipants with obesity or o verweight w ith at least one w eight- r elated c omorbidity have been d osed in a U.